Evaluation and management of diastolic heart failure

Circulation

Volumn 107, Issue 5, 2003, Pages 659-663

  Angeja, Brad G ^a   Grossman, William ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ANGIOTENSIN; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; LOSARTAN; NEUROHORMONE; SPIRONOLACTONE; VERAPAMIL;

CARDIOVASCULAR RISK; CARDIOVERSION; CLINICAL FEATURE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CORONARY ARTERY BLOOD FLOW; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIALYSIS; DIASTOLE; ENDOCARDIAL DISEASE; HEART MUSCLE COMPLIANCE; HEART MUSCLE RELAXATION; HORMONAL REGULATION; HUMAN; MYOCARDIAL DISEASE; NONHUMAN; PATHOPHYSIOLOGY; PERICARDIAL DISEASE; PRIORITY JOURNAL; REVASCULARIZATION; REVIEW;

AGED; DIASTOLE; DYSPNEA; FEMALE; HEART FAILURE, CONGESTIVE; HEART FUNCTION TESTS; HUMANS; HYPERTENSION; MYOCARDIAL ISCHEMIA; PULMONARY EDEMA; RENIN-ANGIOTENSIN SYSTEM; RISK FACTORS;

EID: 0037432149     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000053948.10914.49     Document Type: Review

References (33)

1. Grossman W. Defining diastolic dysfunction. Circulation. 2000;101:2020-2021.
2. Banerjee P, Banerjee T, Khand A, et al. Diastolic heart failure: neglected or misdiagnosed? J Am Coll Cardiol. 2002;39: 138-141.
3. Vasan RS, Larson MG, Benjamin EJ, et al. Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort. J Am Coll Cardiol. 1999;33:1948-1955.
4. Kitzman DW, Gardin JM, Gottdiener JS, et al. Importance of heart failure with preserved systolic function in patients > or = 65 years of age. CHS Research Group Cardiovascular Health Study. Am J Cardiol. 2001;87: 413-419.
5. Zile MR, Brutsaert DL. New concepts in diastolic dysfunction and diastolic heart failure: part I. Circulation. 2002;105: 1387-93.
6. Zile MR, Brutsaert DL. New concepts in diastolic dysfunction and diastolic heart failure: part II. Circulation. 2002;105: 1503-1508.
7. Senni M, Redfield MM. Heart failure with preserved systolic function: a different natural history? J Am Coll Cardiol. 2001;38: 1277-1282.
8. Gottdiener JS, McClelland RL, Marshall R, et al. Outcome of congestive heart failure in elderly persons: influence of left ventricular systolic function. The Cardiovascular Health Study. Ann Intern Med. 2002;137:631-639.
9. Aroesty JM, McKay RG, Heller GV, et al. Simultaneous assessment of left ventricular systolic and diastolic dysfunction during pacing-induced ischemia. Circulation. 1985; 71:889-900.
10. Cain BS, Meldrum DR, Joo KS, et al. Human SERCA2a levels correlate inversely with age in senescent human myocardium. J Am Coll Cardiol. 1998;32:458-467.
11. del Monte F, Williams E, Lebeche D, et al. Improvement in survival and cardiac metabolism after gene transfer of sarcoplasmic reticulum Ca(2+)-ATPase in a rat model of heart failure. Circulation. 2001;104:1424-1429.
12. Lopez B, Gonzalez A, Varo N, et al. Biochemical assessment of myocardial fibrosis in hypertensive heart disease. Hypertension. 2001;38:1222-1226.
13. Watanabe J, Levine MJ, Bellotto F, et al. Left ventricular diastolic chamber stiffness and intramyocardial coronary capacitance in isolated dog hearts. Circulation. 1993;88: 2929-2940.
14. Stern S. Angina pectoris without chest pain: clinical implications of silent ischemia. Circulation. 2002;106:1906-1908.
15. Watanabe J, Levine MJ, Bellotto F, et al. Effects of coronary venous pressure on left ventricular diastolic distensibility. Circ Res. 1990;67:923-932.
16. Friedrich SP, Lorell BH, Rousseau MF, et al. Intracardiac angiotensin-converting enzyme inhibition improves diastolic function in patients with left ventricular hypertrophy due to aortic stenosis. Circulation. 1994;90: 2761-2771.
17. Schunkert H, Jackson B, Tang SS, et al. Distribution and functional significance of cardiac angiotensin converting enzyme in hypertrophied rat hearts. Circulation. 1993; 87:1328-1339.
18. Flesch M, Schiffer F, Zolk O, et al. Angiotensin receptor antagonism and angiotensin converting enzyme inhibition improve diastolic dysfunction and Ca(2+)-ATPase expression in the sarcoplasmic reticulum in hypertensive cardiomyopathy. J Hypertens. 1997;15:1001-1009.
19. Yamamoto K, Masuyama T, Sakata Y, et al. Local neurohumoral regulation in the transition to isolated diastolic heart failure in hypertensive heart disease: absence of ATI receptor downregulation and 'overdrive' of the endothelin system. Cardiovasc Res. 2000;46:421-432.
20. Pitzalis MV, Iacoviello M, Massari F, et al. Influence of gender and family history of hypertension on autonomic control of heart rate, diastolic function and brain natriuretic peptide. J Hypertens. 2001;19:143-148.
21. Vasan RS, Levy D. Defining diastolic heart failure: a call for standardized diagnostic criteria. Circulation. 2000;101:2118-2121.
22. Gandhi SK, Powers JC, Nomeir AM, et al. The pathogenesis of acute pulmonary edema associated with hypertension. N Engl J Med. 2001;344:17-22.
23. Vitarelli A, Gheorghiade M. Diastolic heart failure: standard Doppler approach and beyond. Am J Cardiol. 1998;81:115G-121G.
24. Morrison LK, Harrison A, Krishnaswamy P, et al. Utility of a rapid B-natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnea. J Am Coll Cardiol. 2002;39:202-209.
25. Lubien E, DeMaria A, Krishnaswamy P, et al. Utility of B-natriuretic peptide in detecting diastolic dysfunction: comparison with Doppler velocity recordings. Circulation. 2002;105:595-601.
26. Matsumoto A, Hirata Y, Momomura S, et al. Effects of exercise on plasma level of brain natriuretic peptide in congestive heart failure with and without left ventricular dysfunction. Am Heart J. 1995;129:139-145.
27. The effect of digoxin on mortality and morbidity in patients with heart failure. The Digitalis Investigation Group. N Engl J Med. 1997;336:525-533.
28. Yu CM, Wang Q, Lau CP, et al. Reversible impairment of left and right ventricular systolic and diastolic function during short-lasting atrial fibrillation in patients with an implantable atrial defibrillator: a tissue Doppler imaging study. Pacing Clin Electrophysiol. 2001;24:979-88.
29. Warner JG Jr, Metzger DC, Kitzman DW, el al. Losartan improves exercise tolerance in patients with diastolic dysfunction and a hypertensive response to exercise. J Am Coll Cardiol. 1999;33:1567-1572.
30. Dahlof B, Devereux RB, Kjeldsen SE, et al. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet. 2002;359:995-1003.
31. Diez J, Querejeta R, Lopez B, et al. Losartan-dependent regression of myocardial fibrosis is associaled with reduction of left ventricular chamber stiffness in hypertensive patients. Circulation. 2002;105: 2512-2517.
32. Zannad F, Dousset B, Alla F. Treatment of congestive heart failure: interfering the aldosterone-cardiac extracellular matrix relationship. Hypertension. 2001;38: 1227-1232.
33. Gibbons RJ, Chatterjee K, Daley J, et al. ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: executive summary and recommendations: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients with Chronic Stable Angina). Circulation. 1999; 99:2829-2848.